ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.60
0.71%
US Tech 100
19,636.04
0.55%
S&P 500
5,770.20
0.55%
US Dollar vs CAD
1.43715
0.00%
Bitcoin
86,218.60
0.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aptose Biosciences Inc (APTO) Share Price

Aptose Biosciences Inc

Aptose Biosciences Inc (APTO)

NASDAQ
3.17
0.22
(7.46%)
Closed March 08 3:00PM
Delayed by 15 minutes
3.09
-0.08
(-2.52%)
After Hours: 6:59PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
3.17
Bid
2.70
Ask
5.00
Volume
17,610
2.8232 Day's Range 3.16
0.11 52 Week Range 3.81
Market Cap
6.794M
Previous Close
2.95
Open
2.94
Last Trade
2
@
3.051
Last Trade Time
Financial Volume
US$ 52,286
VWAP
2.9691
Average Volume (3m)
13,233,648
Shares Outstanding
2,143,372
Dividend Yield
-
PE Ratio
-0.13
Earnings Per Share (EPS)
-23.89
Revenue
-
Net Profit
-51.21M

About Aptose Biosciences Inc

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Lux... Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.aptose.com
Headquarters
Mississauga, Ontario, Can
Founded
-
Aptose Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APTO. The last closing price for Aptose Biosciences was US$2.95. Over the last year, Aptose Biosciences shares have traded in a share price range of US$ 0.11 to US$ 3.81.

Aptose Biosciences currently has 2,143,372 shares outstanding. The market capitalization of Aptose Biosciences is US$6.32 million. Aptose Biosciences has a price to earnings ratio (PE ratio) of -0.13.

Ask ADVFN Intelligence (AI)

APTO Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
February 21 2025
APTO (7.46%)

Form 8-K - Current report
Edgar (US Regulatory)
February 20 2025
APTO (7.46%)

Form 8-K - Current report
Edgar (US Regulatory)
February 18 2025
APTO (7.46%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
February 13 2025
APTO (7.46%)

Form 8-K - Current report
Edgar (US Regulatory)
February 13 2025
APTO (7.46%)

Form 8-K - Current report
Edgar (US Regulatory)
February 13 2025
APTO (7.46%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0050.1579778830963.1653.222.3937529212.89590429CS
42.98991660.13325930.18013.810.11172950180.20870508CS
122.97971565.790856540.19033.810.11132336480.23716324CS
262.818800.5681818180.3523.810.1161055750.23673591CS
521.4887.5739644971.693.810.1131371720.25077819CS
156-13.33-80.787878787916.523.250.1111807961.53995231CS
260-108.13-97.1518418688111.31380.11128648833.30109666CS

APTO - Frequently Asked Questions (FAQ)

What is the current Aptose Biosciences share price?
The current share price of Aptose Biosciences is US$ 3.17
How many Aptose Biosciences shares are in issue?
Aptose Biosciences has 2,143,372 shares in issue
What is the market cap of Aptose Biosciences?
The market capitalisation of Aptose Biosciences is USD 6.32M
What is the 1 year trading range for Aptose Biosciences share price?
Aptose Biosciences has traded in the range of US$ 0.11 to US$ 3.81 during the past year
What is the PE ratio of Aptose Biosciences?
The price to earnings ratio of Aptose Biosciences is -0.13
What is the reporting currency for Aptose Biosciences?
Aptose Biosciences reports financial results in USD
What is the latest annual profit for Aptose Biosciences?
The latest annual profit of Aptose Biosciences is USD -51.21M
What is the registered address of Aptose Biosciences?
The registered address for Aptose Biosciences is 5955 AIRPORT ROAD, MISSISSAUGA, ONTARIO, L4V 1R9
What is the Aptose Biosciences website address?
The website address for Aptose Biosciences is www.aptose.com
Which industry sector does Aptose Biosciences operate in?
Aptose Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABLVAble View Global Inc
US$ 1.73
(137.18%)
5.14M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
DWTXDogwood Therapeutics Inc
US$ 6.63
(49.66%)
25.92M
KZIAKazia Therapeutics Ltd
US$ 1.1899
(40.80%)
4.5M
ALBTAvalon GloboCare Corporation
US$ 6.96
(-36.15%)
577.55k
SCNXScienture Holdings Inc
US$ 1.55
(-35.68%)
1.59M
ACXPAcurx Pharmaceuticals Inc
US$ 0.4572
(-29.88%)
1.18M
RETOReTo Eco Solutions Inc
US$ 5.42
(-27.73%)
108.27k
OCTOEightco Holdings Inc
US$ 1.08
(-27.03%)
336.99k
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
618.03M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
476.73M
NVDANVIDIA Corporation
US$ 112.69
(1.92%)
333.91M
ICONIcon Energy Corporation
US$ 0.169898
(17.17%)
140.23M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.675
(-0.70%)
140.05M

APTO Discussion

View Posts
Zeppo Zeppo 3 days ago
Wow.......$2.67. This thing might be ready for a "buy" after the next reverse split. There won't be much stock left.
šŸ‘ļø0
Zeppo Zeppo 1 week ago
So....in three days post split the stock has dropped from $3.64 to $3.09.
šŸ‘ļø0
TrendTrade2016 TrendTrade2016 1 week ago
APTO POST SPLIT POPPA
šŸ‘ļø0
getmoreshares getmoreshares 2 weeks ago
1 for 30 R/S on Feb 26th
šŸ‘ļø0
green maschine green maschine 2 weeks ago
R/S on Feb 26th
šŸ‘ļø0
Zeppo Zeppo 2 weeks ago
Today's press release refers to Round 3 of dosage experiments.......this time with the combo.
šŸ‘ļø0
Triple nickle Triple nickle 2 weeks ago
For the time being it's holding on .32 ??????
šŸ‘ļø0
glenn1919 glenn1919 2 weeks ago
APTO.....................................https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
GalacticDruid45 GalacticDruid45 3 weeks ago
REVERSE SPLIT APPROVED ( JANUARY 27, 2025 )... REVERSE SPLIT DATE ANNOUNCEMENT IMMINENT
👍️ 1
Zeppo Zeppo 3 weeks ago
You'll notice that recent announcements have NOT propelled the stock upward. Reverse splits are not dilutive, but new stock offerings, to the public or as a private placement, are dilutive because they do affect the percentage of ownership for each shareholder. The product results news has been positive so far, but it will take administering the product to many more patients just to get out of Phase 1/2 and into Phase 3. I assume these stock offerings will be made post-split.
šŸ‘ļø0
Invest-in-America Invest-in-America 3 weeks ago
APTO: I have to take a SONG break!! (My new Los Angeles County, California, THEME SONG!! Which should be REQUIRED LISTENING for all the STUPID County Officials who reside therein. As auditory PUNISHMENT, of sorts, for NEVER doing what has had to be accomplished there for 70+-YEARS!!! Namely, systematically REMOVING FOREVER every single TREE, BUSH, SHRUB, & BLADE OF GRASS therein!!! For at least 1.5-MILES around all housing developments throughout that stupid County!!! And then COVER that entire area permanently with GRAVEL, STONE, CONCRETE, STAINLESS STEEL, etc., FOREVER!!!)

šŸ‘ļø0
Invest-in-America Invest-in-America 3 weeks ago
APTO: Looks like this has a Wall Street Police ROADBLOCK at $0.25 cents!!! (DAMN-IT!!!)
šŸ‘ļø0
Invest-in-America Invest-in-America 3 weeks ago
APTO: And I hope ya take us BOTH to $2.00, by the end of this SLOOOOOOOOW day, Bro!!!!
šŸ‘ļø0
LowFloatLopes LowFloatLopes 3 weeks ago
In at .24 
šŸ‘ļø0
Invest-in-America Invest-in-America 3 weeks ago
APTO: Holy STOCK EXPLOSION, Batman!!! What-the-FLUCK was that???!!! (Fret not, Robin!!! Just continue our glorious laughin'-&-runnin' all the way to our BANK!!!)

šŸ‘ļø0
Invest-in-America Invest-in-America 3 weeks ago
APTO: I grabbed some. (But, any "DD" behind this firm is [supposedly] not very encouraging; hope I'm WRONG!!)
šŸ‘ļø0
PinkPennies PinkPennies 3 weeks ago
APTO very nice news

Three patients with unmutated (wildtype) FLT3 (FLT3-WT) completed Cycle 1 of treatment with no dose-limiting toxicities (DLTs) and no dose adjustments.

Two FLT3-WT patients achieved complete remissions (CR and CRh) by the end of Cycle 1.

Notably, a patient with biallelic TP53 mutations and a complex karyotype obtained CR.

The third FLT3-WT patient experienced significant reductions in bone marrow leukemic blasts during Cycle 1 and remains on therapy in Cycle 2.
šŸ‘ļø0
Dantheoneman Dantheoneman 4 weeks ago
Ticker: NXU. 600 Billion Market Merge just Approved! Moon 
šŸ‘ļø0
TrendTrade2016 TrendTrade2016 4 weeks ago
I SEE A RS HAS BEEN VOTED IN 1-10 TO 1-30
šŸ‘ļø0
TrendTrade2016 TrendTrade2016 4 weeks ago
APTO 6 WEEKS TO DELIST...SO RS NEWS SHOULD COME SOON...
šŸ‘ļø0
Invest-in-America Invest-in-America 4 weeks ago
APTO: Nice news!!!
https://finance.yahoo.com/news/aptose-frontline-triple-drug-therapy-120000446.html
šŸ‘ļø0
glenn1919 glenn1919 4 weeks ago
APTO.........................https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
Zeppo Zeppo 1 month ago
Well......have you all seen the latest correspondence from the company? Yup........another reverse split is on the way. I was ornery and voted against it.
šŸ‘ļø0
glenn1919 glenn1919 2 months ago
APTO..........https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
Scotty9 Scotty9 2 months ago
Looks like a Iā€™m going to take a loss on this one
šŸ‘ļø0
Zeppo Zeppo 3 months ago
Okay, everyone. The company basically has three months to get its act together and retain its NASDAQ listing. No revenues are projected for 2025. These new collaborations are going to take time to develop. The last time the company had to scramble to retain its NASDAQ listing, what did it have to do? A reverse split. The company hasn't even been able to find its own way to Phase !!! testing with Tus....let alone Lux. So....what is it going to have to do again....unless its gets some blockbuster FDA news by March 31? Another reverse split. This day has been coming since the last reverse split was done.
šŸ‘ļø0
glenn1919 glenn1919 3 months ago
apto............................https://stockcharts.com/h-sc/ui?s=apto&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
knrorrel knrorrel 3 months ago
https://ih.advfn.com/stock-market/NASDAQ/aptose-biosciences-APTO/stock-news/95133778/aptose-announces-positive-decision-by-nasdaq-heari
šŸ‘ļø0
knrorrel knrorrel 3 months ago
lol


sorry
šŸ‘ļø0
knrorrel knrorrel 3 months ago
lol - nice Post
šŸ‘ļø0
tw0122 tw0122 3 months ago
Nice making another round 
šŸ‘ļø0
Invest-in-America Invest-in-America 3 months ago
"EOIC", like at this link???
https://www.google.com/search?q=What+does+%22EOIC%22+mean+in+street+slang%3F&sca_esv=790e11adc1912a92&source=hp&ei=YJ1kZ8HrO-PbkPIPxKCYyAY&iflsig=AL9hbdgAAAAAZ2SrcT_uYmDaX2twpgyJ6L581HqdxC_A&ved=0ahUKEwjBm6ST8LSKAxXjLUQIHUQQBmkQ4dUDCBU&oq=What+does+%22EOIC%22+mean+in+street+slang%3F&gs_lp=Egdnd3Mtd2l6IiZXaGF0IGRvZXMgIkVPSUMiIG1lYW4gaW4gc3RyZWV0IHNsYW5nPzIHECEYoAEYCjIHECEYoAEYCjIHECEYoAEYCjIHECEYoAEYCkjywwJQAFi7dnAEeACQAQCYAeUBoAG1HKoBBzE2LjEzLjO4AQzIAQD4AQGYAiSgAssgwgIKEAAYgAQYRhj5AcICCBAAGIAEGLEDwgIFEAAYgATCAg4QABiABBixAxiDARiKBcICBxAAGIAEGArCAgwQABiABBgKGEYY-QHCAgcQABiABBgNwgIGEAAYFhgewgIIEAAYCBgNGB7CAgsQABiABBiGAxiKBcICCBAAGIAEGKIEwgIFECEYqwKYAwCSBwcxMy4yMC4zoAeN-wE&sclient=gws-wiz
////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
Or, did you mean to type, "EPIC"????
šŸ‘ļø0
Invest-in-America Invest-in-America 3 months ago
APTO: No brainer here, K-N-R, in my STUPID opinion!!! (Heck, I just scalped a cheap Lotto Ticket [$1K] on @NVDI in the Post-M several minutes ago for $300 profit; 'small potatoes' for sure, but given this latest rage of JUST-RESCUED-FOR-CONTINUED-NASDAQ-LISTING late PR's, who can resist this stuff???!!!)
👍️ 1
knrorrel knrorrel 3 months ago
Sounds eoic
šŸ‘ļø0
knrorrel knrorrel 3 months ago
holy ahi_ ....coming Dollarland tomorrow ??
šŸ‘ļø0
Invest-in-America Invest-in-America 3 months ago
APTO: Flip-&-scalp these NASDAQ orphans all day long!!!
šŸ‘ļø0
Invest-in-America Invest-in-America 3 months ago
APTO: Back on the NASDAQ, a little more securely!!! (Another 10-bagger???)
šŸ‘ļø0
TheFinalCD TheFinalCD 3 months ago
https://x.com/AlertsAndNews/status/1869852144951799886
šŸ‘ļø0
Zeppo Zeppo 4 months ago
Well....a Phase III push for Tus is on the back burner again. First the company decides to go it alone but can't decide on a dosage. Then it wants to partner with a 2nd party.......and now a 3rd. Comments, anyone?
šŸ‘ļø0
tw0122 tw0122 6 months ago
In some .38s looks bottomy typical hedgie beat down bio
šŸ‘ļø0
Monksdream Monksdream 6 months ago
APTO new 52=week low
šŸ‘ļø0
Monksdream Monksdream 6 months ago
APTO new 52 week low
šŸ‘ļø0
Zeppo Zeppo 6 months ago
Another reverse split seems inevitable. The cash infusion, hopefully, will hasten the company to eventually reach a Phase III status on Tusp sometime during my lifetime.
šŸ‘ļø0
Laster Laster 6 months ago
Bought some AH Friday. What a huge mistake.
Looks like today it will retrace back to $0.50 or lower.
Oh well.
šŸ‘ļø0
glenn1919 glenn1919 6 months ago
APTO.....................................https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
Imokhopeur Imokhopeur 7 months ago
Buy
šŸ‘ļø0
Lilman72003 Lilman72003 7 months ago
Iā€™m in
šŸ‘ļø0
Monksdream Monksdream 7 months ago
APTO new 52 week low
šŸ‘ļø0
Monksdream Monksdream 8 months ago
APTO new 52 week low
šŸ‘ļø0
Zeppo Zeppo 8 months ago
True to form, no revenue projections for the foreseeable future has relegated APTO to a pre-reverse split value of $.05.
šŸ‘ļø0

Your Recent History

NASDAQ
APTO
Aptose Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads